ÂÜÀòÂÒÂ×

Wolfram Brugger is currently the VP and Head of Clinical Development at Autolus Therapeutics, where they focus on advancing methodologies in hematology and oncology. With a rich background as a hematologist/oncologist, Wolfram has developed expertise in a variety of malignant diseases, including lymphomas, leukemias, and lung cancer. They previously held significant roles at MorphoSys and AstraZeneca, contributing to numerous clinical studies in oncological research. Wolfram earned their MD and underwent residency training in internal medicine at the University of Freiburg, and has served as an associate professor and head of various departments in esteemed medical institutions.